Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The present study aims to investigate the effect of pioglitazone (30 mg/day) on endothelial
function in premenopausal women with SLE (systemic lupus erythematosus). Patients with
hypertension, endocrine, hepatic or renal diseases will not be included, or pregnant /breast
feeding women. This is a randomized, double blind, placebo controlled study.
Phase:
Phase 4
Details
Lead Sponsor:
National Heart Institute, Mexico
Collaborators:
National Council of Science and Technology, Mexico Universidad Nacional Autonoma de Mexico